Exploring modern approaches to identify novel drug targets using genomics, proteomics, and AI-driven tools. This session highlights how precision biology uncovers disease mechanisms and accelerates therapeutic innovation.

How molecular modeling and simulations accelerate the discovery of safe and effective compounds. We’ll discuss case studies where in silico design reduced costs and timelines significantly.

Latest innovations in automated screening platforms for rapid compound evaluation. Learn how robotics and data analytics enable testing of thousands of molecules in days.

Harnessing medicinal plants and traditional knowledge for modern therapeutic development. This session bridges Ayurveda with modern pharmacology to unlock new drug leads.

Applications of crystallography, NMR, and cryo-EM in rational drug design. Experts will show how structural insights guide the creation of highly specific molecules.

Case studies on predictive algorithms transforming drug development pipelines. We’ll explore how AI reduces attrition rates and improves hit-to-lead success.

Understanding drug absorption, distribution, metabolism, and excretion for optimized therapies. This session emphasizes modeling techniques that predict human responses more accurately.

Role of biomarkers in patient stratification and personalized medicine. Discussions will cover regulatory acceptance and integration into trial designs.

Innovative approaches to reposition existing drugs for new indications. Learn how COVID-19 accelerated repurposing as a mainstream discovery pathway.

Navigating CDSCO guidelines and global harmonization for drug approvals. Experts will share practical insights on dossier preparation and compliance.

Animal models and organ-on-chip technologies bridging lab to clinic. We’ll examine how predictive models reduce failure rates in human trials.

Ensuring drug safety through advanced toxicological studies and predictive models. This session highlights computational toxicology and ethical alternatives to animal testing.

Novel strategies to combat antibiotic resistance and emerging pathogens. Discussions include phage therapy, novel scaffolds, and global collaboration needs.

Breakthroughs in targeted therapies, immuno-oncology, and combination treatments. We’ll explore how precision medicine reshapes cancer care and survival outcomes.

Drug discovery efforts for Alzheimer’s, Parkinson’s, and related disorders. Sessions highlight biomarkers, gene therapy, and novel neuroprotective agents.

Innovations in therapies for hypertension, heart failure, and arrhythmias. Learn how big data and AI improve cardiovascular risk prediction.

Challenges and opportunities in developing treatments for underserved conditions. We’ll discuss incentives, patient advocacy, and global collaboration models.

Advances in monoclonal antibodies, peptides, and biosimilar development. This session covers manufacturing challenges and regulatory pathways in India.

Emerging technologies in rapid vaccine design and delivery systems. Learn how mRNA and vector-based vaccines are reshaping public health.

Smart nanoparticles and nanocarriers for targeted drug release. Case studies show improved efficacy and reduced side effects in therapy.

Adaptive trial designs, digital monitoring, and patient-centric approaches. We’ll explore how technology improves efficiency and inclusivity in trials.

Building partnerships to accelerate translational drug discovery. Examples highlight successful joint ventures and funding opportunities.

Protecting innovations while balancing accessibility and affordability. This session covers patent strategies, licensing, and global IP trends.

Encouraging young innovators to launch biotech ventures in India. We’ll discuss funding, incubation, and scaling challenges for startups.

Visionary panel on integrating AI, big data, and indigenous resources for global leadership. This closing session sets a roadmap for India’s role in affordable innovation.